using tirzepatide and retatrutide together Switching from to Retatrutide? - GLP-1 Weight Loss | Hormones | Peptides Retatrutide vs Mounjaro: triple agonist

2000

Different tolerability issues: Both can cause gastrointestinal symptoms, but the risk patterns differ

Empfohlene Dosierung nicht berschreiten

Tirzepatide is the agonist of GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor, which can reduce body weight and improve cardiac metabolism by subcutaneous injection once a week (Jastreboff et al 2022)

I still believe its important to be long potential moonshot names like Credo Technologies in this space as well

Immediate Stabilization (ABC) Airway: secure if decreased consciousness Breathing: oxygen if needed Circulation: IV access, fluid management Monitor: BP Blood glucose Temperature GCS (Glasgow Coma Scale) 2